Experienced in Progressive Multifocal Leukoencephalopathy

Luisa V. Klotz

Muenster, NW, DE 
Experienced in Progressive Multifocal Leukoencephalopathy
Muenster, NW, DE 
OverviewLocationsClinical Research

Overview

Luisa Klotz practices in Muenster, Germany. Ms. Klotz is rated as an Experienced expert by MediFind in the treatment of Progressive Multifocal Leukoencephalopathy. Her top areas of expertise are Multiple Sclerosis (MS), CACH Syndrome, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, and Neuromyelitis Optica.

Her clinical research consists of co-authoring 184 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Progressive Multifocal Leukoencephalopathy.

Gender
Female

Locations

Muenster, NW, Germany
Other Locations
Berlin, BE, Germany
Heidelberg, BW, Germany
Hannover, NI, Germany
Gutenberg, RP, Germany
Dresden, SN, Germany
Munich, BY, Germany
Duesseldorf, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
A 24-week, Multicenter, Exploratory, Two Arm Study to Assess the Effect of Dimethyl Fumarate on Immune-Modulatory Action on T Cells in Patients With Relapsing Remitting Multiple Sclerosis (DIMAT-MS)
Enrollment Status: Completed
Publish Date: October 11, 2018
Intervention Type: Drug
Study Phase: Phase 4

184 Total Publications

HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis.
Journal: EBioMedicine
Published: May 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Klotz's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile